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Abstract
Background: The purpose of this study was to report the anterior chamber (AC) depth and the attack of angle-closure
glaucoma (ACG) in eyes with the recent onset of central retinal vein occlusion (CRVO).
Methods: This retrospective case series included 24 patients with recent onset of CRVO (within one month of attack)
from July 2001 to December 2002. The mean follow-up period of the patients was 46 months (range: 3 to 92 months).
AC depth was measured using an ultrasound biomicroscopy. Clinical data, including systemic disorders, intraocular
pressure, and visual outcomes were recorded. The main outcome measures were AC depth in the diseased eye and
the fellow eye of the same patient and the attack of ACG after CRVO.
Results: The mean AC depth in the diseased eyes was significantly shallower than in the unaffected fellow eyes
(2.43 ± 0.45 mm vs. 2.55 ± 0.46 mm; p < 0.001). Four patients (17 %) developed ACG after the onset of CRVO within
one month of the CRVO attack. In these four patients, the mean AC depth in the diseased eyes was 1.91 ± 0.21 mm,
which was much shallower than the eyes without ACG attack (2.53 ± 0.40 mm).
Conclusions: AC depth is significantly shallower following the onset of CRVO. ACG can occur in patients after the
onset of CRVO.
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Background
Glaucoma may be a contributory factor in the etiology
of central retinal vein occlusion (CRVO), or may be a re-
sult of CRVO [1]. Neovascular glaucoma (NVG) is the
most common form of glaucoma following CRVO [2, 3].
NVG mostly results from an elevated expression of
vascular endothelial growth factor (VEGF) following the
ischemic onset of vessel occlusion in the retina [4, 5].
However, shallowing of the anterior chamber (AC) fol-
lowing the onset of occlusion in CRVO, therefore result-
ing in asymmetric AC depths in the same patient, has
been observed [6]. Clinical observations have shown that
angle-closure glaucoma (ACG) can occur following
CRVO without the formation of neovascularization in
the angle of the eyes, although with a much lower
incidence than NVG [7–11]. However, these previous
studies are mainly case reports. The shallowing of AC is
mainly observational without actual measurement of it.
The purpose of this study was to investigate the AC
depth by an ultrasound biomicroscopy (UBM) in pa-
tients with acute onset of CRVO and the incidence of
ACG following CRVO in a consecutive series of CRVO
patients. We hope that our findings can provide more
in-depth observations and a better understanding of the
association of CRVO and the onset of ACG.
Methods
This retrospective study was approved by the Institu-
tional Review Board of Chang Gung Memorial Hospital
and conforms to the provisions of the Declaration of
Helsinki. Consecutive patients with recent onset of
CRVO (within one month of attack) from July 2001 to
December 2002 were collected and analyzed. Patients
who had received panretinal photocoagulation before
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the measurement of AC depth were excluded from the
study. Patients who had undergone cataract surgery be-
fore the onset of CRVO either in the diseased or fellow
eyes were also excluded. AC depth was measured using
an UBM (P40; Paradigm Medical Industries, Inc. Salt
Lake City, UT). Measurements were made from the cen-
ter of anterior surface of the lens to the central apex of
corneal endothelium in the diseased eye and the fellow
eye of the same patient (Fig. 1). Each eye was measured
three times and the mean depth was calculated. Gonio-
scopy was also performed to evaluate the status of the
angle in these patients. Clinical data, including systemic
disorders, intraocular pressure, and visual outcomes,
were recorded. All of the patients were followed-up for
at least three months. All of the data were expressed as
mean ± standard deviation (SD). The paired t test was
used for comparisons of the AC depth between the
diseased and unaffected eyes. The Shapiro-Wilk test was
conducted to test the normality of the numerical vari-
ables. Statistical analysis was performed using SPSS
(version 12.0 for Windows, SPSS Inc., Chicago, IL). A
p value of less than 0.05 was considered to indicate
statistical significance in this study.
Results
Twenty-four patients (13 males, 11 females) were in-
cluded in this study, with a mean age of 62.7 ± 12.3 years
(range: 25–77 years). Hypertension was noted in five
patients and diabetic mellitus was also noted in five pa-
tients. The affected left to right eye ratio was 12 to 12,
and the ratio of ischemic CRVO to non-ischemic CRVO
was 7 to 17. All of the diseased and fellow eyes were
phakic. Twenty-three out of 24 (95 %) affected eyes of
the 24 patients had a shallower AC depth than the
unaffected eyes, with a mean AC depth of 2.43 ±
0.45 mm (range: 1.66–3.19 mm) in the diseased eyes and
2.55 ± 0.46 mm (range: 1.71–3.22 mm) in the unaffected
eyes. The mean difference between the affected and
unaffected eyes was 0.12 ± 0.10 mm (range: −0.03–
0.34 mm) and was statistically significant (p <0.001;
paired t test). The AC depths in the diseased and un-
affected fellow eyes in the 24 patients with CRVO are
shown in Table 1. Of the 23 patients who had a shal-
lower AC depth of the affected eyes, we found that a dif-
ference of ≥0.1 mm between the affected and unaffected
eyes accounted for 61 % of the patients (Table 2). Four
patients (17 %) developed ACG within one month after
the onset of CRVO occurred. The profiles of these four
patients are shown in Table 3. Intraocular pressure ele-
vation ranged from 28 to 37 mmHg. The angles in these
four patients were closed without neovascularization. Of
these four patients, two (50 %) had narrow angles and
had received prophylactic laser iridotomy before the at-
tack of CRVO. (case 1 and case 4 in Table 3) The other
two patients (50 %) (case 2 and case 3 in Table 3) had
very shallow AC without iris bombe following CRVO.
Gonioscopy revealed a very narrow angle, only minimal
anterior part of the trabecular meshwork being visible.
Laser iridotomy was performed in these two patients. In
these four patients, the mean AC depth in the diseased
eyes was 1.91 ± 0.21 mm (range: 1.66–2.16 mm), and
1.99 ± 0.36 mm (range: 1.71–2.49 mm) in the unaffected
eyes. The AC depth in these four eyes was much
shallower than in the eyes without ACG attack (2.53 ±
0.40 mm) and the unaffected fellow eyes (2.66 ±
0.41 mm). In these four eyes, intraocular pressure (IOP)
was under control after the application of laser iridot-
omy or anti-glaucoma medication. In the other 20 pa-
tients (83 %), IOP was within normal range (less than or
equal to 22 mmHg) in both eyes. Gonioscopic evaluation
showed open angles. Neither involved eyes nor un-
involved eyes demonstrated neovascularization over the
angles. Four eyes received pan-retinal photocoagulation
Fig. 1 Anterior chamber depth was measured using an ultrasound
biomicroscopy (UBM). Measurements were made from the anterior
surface of the lens to corneal endothelium in the affected eye and
fellow eye of the same patient (arrow)
Table 1 Anterior chamber depth in the diseased eyes with
central retinal vein occlusion and the unaffected fellow eyes in
24 patients
AC depth CRVO eyes Fellow eyes Differencea
Mean ± SD 2.43 ± 0.45 mm 2.55 ± 0.46 mm 0.12 ± 0.1 mm*
Range 1.66–3.19 mm 1.71–3.22 mm −0.03–0.34 mm
AC anterior chamber, CRVO central retinal vein occlusion, SD
standard deviation
aOf 24 patients enrolled, only one patient (4 %) had a deeper anterior
chamber depth in the CRVO eye than the fellow eye
*p < 0.001 (Paired t test)
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following the onset of CRVO, and three eyes received vi-
trectomy and radial optic neurotomy for the ischemic
CRVO. None of the eyes developed NVG after these in-
terventions. The mean follow-up period of the patients
was 46 months (range: 3 to 92 months).
Discussion
In this study, we found that the AC depth was signifi-
cantly shallower in the eyes with CRVO attack than in
the fellow eyes. Four patients (17 %) developed ACG
after the onset of CRVO, and the mean AC depth in
these eyes was only 1.91 ± 0.21 mm. Lin et al. [12] re-
ported that in acute ACG patients in Taiwan, the mean
AC depth (corneal thickness included) was 2.28 ±
0.23 mm. Subtracting the average corneal thickness of
0.5 mm, the AC depth was around 1.78 mm in the pa-
tients with ACG attack in Lin et al.’s study, and was con-
sistent with our findings. An AC depth less than 2 mm
may pose a greater risk for ACG clinically. ACG after
CRVO has not been reported extensively. However, these
issues are particularly important for Asians, as Asians have
a shallower AC or a steeper cornea and a much higher
prevalence of ACG than Caucasians [13–18].
Most of the previous studies on non-rubeotic ACG
following CRVO are case reports or small case series
and lack of actual measurement of AC depth [6–9]. Our
study includes a series of CRVO patients with the actual
measurement of AC depth. According to previous case
reports, some common characteristics can be seen in
those patients. First, temporary shallowing of the AC
and reversible ACG without visible vascularization of
the angle were noted. Second, neither evidence of
pupillary block nor iris bombe was found; however, all of
the patients had a rather forward displacement of the
entire lens - iris diaphragm. Third, IOP control was usu-
ally achieved by medical treatment, and laser or surgical
procedures were used as a back-up treatment if the IOP
could not be controlled with anti-glaucoma medications.
In our current study, we also had a very consistent clin-
ical course. The four patients developing ACG had very
shallow AC and revealed no vascularization over the an-
gles. The mechanism of angle closure glaucoma was not
due to papillary block in the two patients since they had
received prophylactic laser iridotomy before. All the pa-
tients got good IOP control after laser surgery and glau-
coma medications.
The association of CRVO and glaucoma is complex.
Pre-existing glaucoma is a well-characterized risk factor
for CRVO [19–31]. CRVO occurs in 3.5 to 5 % of pa-
tients with primary open angle glaucoma [32]. Similarly,
CRVO occurs in approximately 3 % of patients with ocu-
lar hypertension [32]. It is recommended that ocular
hypertensive patients over the age of 65 years be treated
to lower their intraocular pressure to below 25 mm Hg
to reduce the incidence of CRVO [32]. Patients with
CRVO have been found to have a higher IOP, and ocular
hypertensive patients have an increased risk of develop-
ing CRVO [33, 34]. On the other hand, the majority of
glaucoma attack after CRVO, and especially the ischemic
type of CRVO, is NVG [2]. NVG usually occurs 90 days
after CRVO, and therefore the term “90-day glaucoma”
is used. Non-rubeotic ACG is much less common than
the NVG, and usually occurs within one month of
CRVO attack. A proposed scheme of central retinal vein
occlusion (CRVO) and the association with glaucoma is
shown in Fig. 2.
The mechanisms of AC shallowing after CRVO are
uncertain. It has been hypothesized that marked swelling
and vascular congestion of the ciliary body with antero-
lateral displacement after CRVO could lead to decreased
AC depth. It is also likely that the increase in volume
within the posterior segment, either due to blood or
transudative fluid following CRVO pushes the lens-iris
diaphragm forward. This condition may be under-
diagnosed, especially in Asians with a shallower AC than
Caucasians [13–18]. Further prospective studies includ-
ing evaluation of AC depth, angle, and ciliary body
changes in CRVO need to be performed to highlight this
much neglected disorder.
The limitations of this study include its retrospective
design, small sample size, and variable follow-up of the
patients. In addition, no longitudinal follow-up of AC
depth of these patients was performed. However, our
comparative study showed significant shallowing of the
AC following the onset of CRVO. This implies that the
Table 2 Differences of anterior chamber depth in 23 patients
with shallower anterior chamber depth in the central retinal
vein occlusion eyes than the fellow unaffected eyes
Differences of AC (mm) Number of eyes Percentage (%)
0–0.05 mm 3 13
0.05–0.1 mm 6 26
0.1–0.2 mm 7 30
0.2–0.3 mm 5 22
>0.3 mm 2 9
AC anterior chamber
Table 3 Profiles of the patients with angle-closure glaucoma
attacks after central retinal vein occlusion
Patient Age Laterality ACD(mm) ACF(mm) DM HTN FU (m)
1 49 OS 1.650 1.709 No No 93
2 56 OD 2.157 2.469 Yes Yes 92
3 69 OS 1.975 2.002 No No 92
4 61 OD 1.863 1.771 Yes Yes 72
ACD depth of the anterior chamber of the diseased eyes, ACF, depth of the
anterior chamber of the fellow eyes, DM diabetic mellitus, F female, FU follow-up,
HTN hypertension, M male, m month, OD right eye, OS left eye
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patients with recent-onset CRVO need to be monitored
closely, not only for the presence of NVG, but also for
attacks of ACG.
Conclusions
AC shallowing by up to 0.3 mm in eyes after CRVO at-
tack may occur compared with fellow unaffected eyes. It
is important to evaluate AC depth and perform gonio-
scopic examinations in cases of recent-onset CRVO to
assess the possible development of NVG as well as the
frequently ignored ACG. An AC depth of less than
2 mm may pose a greater risk for ACG clinically.
Secondary non-rubeotic ACG from CRVO must be dis-
tinguished from NVG, because the treatment and the
prognosis may differ among the two disease entities.
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